Buchumschlag

Cellular immune responses and immune escape mechanisms in breast cancer: determinants of immunotherapy

Weitere Versionen anzeigen (1)

More recently, immunotherapy has emerged as a novel potentially effective therapeutic option also for solid malignancies such as breast cancer (BC). Relevant approaches, however, are determined by the 2 main elements of cancer immunoediting - the elimination of nascent transformed cells by immunosur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Domschke, Christoph (VerfasserIn) , Schneeweiss, Andreas (VerfasserIn) , Stefanovic, Stefan (VerfasserIn) , Wallwiener, Markus (VerfasserIn) , Heil, Jörg (VerfasserIn) , Rom, Joachim (VerfasserIn) , Sohn, Christof (VerfasserIn) , Beckhove, Philipp (VerfasserIn) , Schütz, Florian (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 27, 2016
In: Breast care
Year: 2016, Jahrgang: 11, Heft: 2, Pages: 102-107
ISSN:1661-3805
DOI:10.1159/000446061
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000446061
Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/446061
Volltext
Verfasserangaben:Christoph Domschke, Andreas Schneeweiss, Stefan Stefanovic, Markus Wallwiener, Joerg Heil, Joachim Rom, Christof Sohn, Philipp Beckhove, Florian Schuetz
Beschreibung
Zusammenfassung:More recently, immunotherapy has emerged as a novel potentially effective therapeutic option also for solid malignancies such as breast cancer (BC). Relevant approaches, however, are determined by the 2 main elements of cancer immunoediting - the elimination of nascent transformed cells by immunosurveillance on the one hand and tumor immune escape on the other hand. Correspondingly, we here review the role of the various cellular immune players within the host-protective system and dissect the mechanisms of immune evasion leading to tumor progression. If the immune balance of disseminated BC cell dormancy (equilibrium phase) is lost, distant metastatic relapse may occur. The relevant cellular antitumor responses and translational immunotherapeutic options will also be discussed in terms of clinical benefit and future directions in BC management.
Beschreibung:Gesehen am 11.05.2020
Beschreibung:Online Resource
ISSN:1661-3805
DOI:10.1159/000446061

Ähnliche Einträge